Scilight Press

Aims

The Advances in Hematology and Cell Therapy (AHCT) journal is a gold open access, peer-reviewed journal that aims to report and contribute to the clinical and translational research in the field of Hematology characterized by quick innovation and continuous progress.

The main objectives of Advances in Hematology and Cell Therapy (AHCT) journal are to spread knowledge by the publication of original research, reviews, and innovative clinical cases; to promote the collaboration by establishing a forum for discussion and sharing of experiences among researchers, clinicians, and hematological health professionals; to improve the clinical practice in the diagnosis, treatment, and management of patients with hematologic diseases and undergoing cell therapy with up-to-date, evidence-based information; to encourage the research by the publication of innovative results on clinical and translational research; to support the education by providing a resource for education and continuing education for professionals in the field; and to increase the awareness of the progresses in the field of hematological diseases and cell therapy among the public and the scientific community. It is published quarterly online by Scilight Press.

Scope

The Advances in Hematology and Cell Therapy (AHCT) journal covers all the aspects related to the management of hematologic diseases and cell therapy, including epidemiology, diagnosis, treatment and complications related to the therapy.

The journal has the following topics of interest:

• Malignant hematological diseases in adult patients (leukemia, lymphoma, myelodysplastic syndromes, multiple myeloma, etc.)
• Non-malignant hematological diseases in adult patients (aplastic anemia, thalassemia, sickle cell disease, etc.)
• Malignant hematological diseases in pediatric patients (leukemia, lymphoma, myelodysplastic syndromes, etc.)
• Non-malignant hematological diseases in adult patients (aplastic anemia, thalassemia, sickle cell disease, Fanconi anemia, Blackfan-Diamond anemia, etc.)
• Primary immunodeficiency
• Stem cell transplantation (hematopoietic and non-hematopoietic)
• Cell therapy
• Gene therapy
• Immunotherapy
• Infectious complications (incidence, diagnosis, and treatment)
• Early treatment-related complications
• Late treatment-related complications
• Pharmacology and toxicology of hematological treatments
• Psychological and social aspects of hematological disease, and cell therapy, and quality of life.